# Zinc Zeolite

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/zinc-zeolite
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Zinc-modified clinoptilolite, Zinc clinoptilolite, Zinc-exchanged zeolite, Zinc aluminosilicate zeolite, Modified zeolite with zinc, Zn-zeolite, Zinc-loaded zeolite, Clinoptilolite-Zn

## Overview

Zinc Zeolite is a form of zinc chelated to a zeolite mineral matrix, which acts as a slow-release carrier to enhance zinc absorption and tissue delivery. Its primary mechanism involves the porous aluminosilicate zeolite framework controlling zinc ion release rate, improving bioavailability over conventional zinc salts like zinc sulfate.

## Health Benefits

• May support [cognitive function](/ingredients/condition/cognitive) in neurodegenerative conditions - animal studies show partial reversal of memory impairments and reduced hippocampal cell death (preliminary evidence)
• Enhanced zinc bioavailability compared to zinc sulfate - animal studies demonstrate improved tissue zinc accumulation (preliminary evidence)
• Well-tolerated in multiple patient populations - human trials show no adverse effects in healthy volunteers, athletes, Crohn's disease, and [osteoporosis](/ingredients/condition/bone-health) patients over 4 years (moderate evidence)
• Potential drug delivery enhancement - in vitro studies show improved sustained release of therapeutic agents to brain tissues (preliminary evidence)
• May reduce markers of neurodegeneration - animal models show decreased phosphorylated tau and amyloid precursor protein expression (preliminary evidence)

## Mechanism of Action

Zinc ions bound within the aluminosilicate zeolite framework are released gradually in the gastrointestinal tract, reducing peak luminal zinc concentrations that typically trigger competing divalent metal transporter-1 (DMT-1) saturation and subsequent malabsorption. Once absorbed, zinc acts as a cofactor for over 300 enzymes including superoxide dismutase (SOD), carbonic anhydrase, and matrix metalloproteinases, while also modulating NMDA receptor activity in hippocampal neurons relevant to [memory](/ingredients/condition/cognitive) consolidation. The controlled-release profile appears to improve tissue zinc accumulation in the liver, kidney, and brain compared to zinc sulfate at equivalent doses in rodent models.

## Clinical Summary

Current evidence for Zinc Zeolite is limited primarily to animal studies, with no large-scale randomized controlled human trials published as of early 2025. Rodent studies have demonstrated statistically significant improvements in spatial [memory](/ingredients/condition/cognitive) tasks and partial reversal of scopolamine-induced memory impairments, alongside measurably reduced hippocampal neuronal apoptosis compared to zinc sulfate controls. Bioavailability studies in animals show superior zinc tissue accumulation in liver and kidney at equivalent oral doses, suggesting improved intestinal uptake efficiency. Human clinical data remains absent, making extrapolation to therapeutic dosing in humans premature and requiring cautious interpretation.

## Nutritional Profile

Zinc Zeolite is a mineral-based zinc delivery system where zinc ions are incorporated into or exchanged within a zeolite (aluminosilicate) framework. Primary active component: Zinc (Zn²⁺), typically comprising 5–15% elemental zinc by weight depending on the zeolite carrier and ion-exchange loading. The zeolite matrix (commonly clinoptilolite or synthetic analogs) consists of silicon dioxide (SiO₂), aluminum oxide (Al₂O₃), and metal oxides in a microporous crystalline lattice. Zinc content per typical supplemental dose: approximately 10–30 mg elemental zinc, though this varies by formulation. Macronutrient contribution is negligible (no caloric value, no significant protein, fat, or carbohydrate). Micronutrient profile centers on zinc as the primary bioactive mineral; trace amounts of calcium, magnesium, potassium, and sodium may be present as residual cations within the zeolite structure depending on source and processing. Bioavailability notes: The zeolite carrier is designed to facilitate controlled, sustained release of zinc ions in the gastrointestinal tract, potentially reducing GI irritation compared to zinc sulfate. Animal studies indicate superior tissue zinc accumulation (liver, bone, brain) versus zinc sulfate at equivalent doses, suggesting enhanced relative bioavailability, estimated at 20–40% improvement over zinc sulfate in preclinical models. The aluminosilicate carrier itself is largely non-absorbed and excreted intact; aluminum bioavailability from the zeolite matrix is considered minimal under normal physiological pH conditions.

## Dosage & Preparation

Specific human dosages are not clearly defined in available clinical literature. Animal studies used 0.23-0.46% zinc-bearing zeolite clinoptilolite in diet (40.25-80.50 mg Zn/kg diet). Human trials used doses adjusted according to EFSA safety data, though specific amounts were not detailed. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Zinc Zeolite shares the general safety profile of zinc supplementation, with excessive intake above the tolerable upper intake level of 40 mg/day for adults risking nausea, vomiting, copper deficiency, and impaired [immune function](/ingredients/condition/immune-support) due to copper-zinc antagonism at DMT-1 transporters. The zeolite carrier itself, composed of aluminosilicate minerals, raises theoretical concerns about aluminum accumulation with chronic high-dose use, though evidence for clinically significant aluminum absorption from food-grade zeolites is limited. Zinc supplementation broadly interacts with fluoroquinolone and tetracycline antibiotics by forming insoluble chelates that reduce antibiotic absorption, and may interfere with iron and copper absorption when taken concurrently. Pregnancy safety follows general zinc guidelines — adequate zinc intake is essential for fetal development, but doses exceeding the 40 mg/day upper limit should be avoided without medical supervision.

## Scientific Research

Human clinical evidence is limited to safety studies with PMA-zeolite tested in three trials: MMBP study (NCT04607018) in healthy volunteers, Morbus Crohn study (NCT04370535), and [Osteoporosis](/ingredients/condition/bone-health) TOP study (NCT03901989) over 4 years. One rat model study (Biol Trace Elem Res. 2025 Aug;203(8):4211-4223) evaluated zeolite zinc in Alzheimer's disease, showing partial reversal of [memory](/ingredients/condition/cognitive) impairments.

## Historical & Cultural Context

The research does not contain information about traditional medicine use of zinc zeolite. Zeolites have been used in industrial applications and veterinary medicine, but specific historical or traditional medical contexts are not documented in the provided sources.

## Synergistic Combinations

Vitamin D3, Magnesium, Vitamin C, Selenium, Copper

## Frequently Asked Questions

### Is zinc zeolite better absorbed than zinc sulfate?

Animal studies indicate zinc zeolite achieves higher tissue zinc concentrations in liver, kidney, and brain compared to zinc sulfate at equivalent oral doses, suggesting improved bioavailability. This is attributed to the controlled-release mechanism of the zeolite matrix reducing DMT-1 transporter saturation in the gut. However, comparative human pharmacokinetic trials have not yet been conducted to confirm this advantage in clinical settings.

### Can zinc zeolite help with memory and cognitive function?

Rodent studies have shown that zinc zeolite supplementation partially reversed scopolamine-induced memory impairments in maze-based spatial memory tests and reduced hippocampal neuronal cell death compared to control groups. These effects are linked to zinc's role as a modulator of NMDA receptors and its antioxidant cofactor activity via superoxide dismutase in brain tissue. No human clinical trials have validated these cognitive benefits, so current evidence remains strictly preliminary.

### What is the recommended dosage for zinc zeolite?

No clinically established human dosage exists specifically for zinc zeolite, as human trials have not been completed. General zinc supplementation guidelines suggest 8–11 mg/day as an adequate intake for adults, with a tolerable upper limit of 40 mg/day set by the Institute of Medicine to avoid adverse effects like copper depletion and gastrointestinal distress. Dosage decisions should be guided by a healthcare provider accounting for dietary zinc intake and individual health status.

### Does zinc zeolite cause any side effects?

Side effects of zinc zeolite are expected to mirror those of zinc supplementation broadly, including nausea, stomach cramps, and vomiting at higher doses, particularly when taken on an empty stomach. Chronic intake above 40 mg/day risks secondary copper deficiency due to competitive inhibition at intestinal DMT-1 transporters, potentially causing anemia and neurological symptoms. The aluminosilicate zeolite component raises a theoretical concern about trace aluminum exposure with long-term use, though this has not been documented as clinically significant in available research.

### Does zinc zeolite interact with antibiotics or other medications?

Like all zinc supplements, zinc zeolite can bind to fluoroquinolone antibiotics (e.g., ciprofloxacin) and tetracyclines (e.g., doxycycline) in the gastrointestinal tract, forming insoluble chelate complexes that reduce antibiotic bioavailability by up to 50%. It is generally recommended to separate zinc supplementation from these antibiotics by at least 2 hours before or 4–6 hours after dosing. Zinc may also reduce the absorption of penicillamine used in rheumatoid arthritis and Wilson's disease treatment, and concurrent high-dose iron supplementation can further compete for shared absorption pathways.

### Is zinc zeolite safe during pregnancy and breastfeeding?

While zinc is an essential nutrient during pregnancy, the safety profile of zinc zeolite specifically in pregnant and breastfeeding women has not been extensively studied in clinical trials. Pregnant and breastfeeding individuals should consult with their healthcare provider before supplementing with zinc zeolite, as they have specific zinc requirements that differ from the general population. Standard prenatal vitamins containing established zinc forms may be a safer alternative until more safety data is available for this particular mineral form.

### Who should consider taking zinc zeolite supplements?

Zinc zeolite may be beneficial for individuals with documented zinc deficiency, those following restrictive diets with limited zinc sources, or people seeking cognitive support during aging. It may also be considered by those who experience poor absorption with standard zinc supplements or who have sensitivity to common zinc forms like zinc sulfate. However, supplementation should be guided by healthcare provider assessment, as excessive zinc intake can interfere with copper absorption and immune function.

### How does the quality of clinical evidence for zinc zeolite compare to other zinc supplements?

Most evidence supporting zinc zeolite comes from animal studies and preliminary research, rather than large-scale human clinical trials, making the strength of evidence moderate at best. While human trials show good tolerability, the cognitive and bioavailability benefits demonstrated in animal models have not yet been definitively confirmed in robust human studies. More rigorous clinical research is needed to establish zinc zeolite's superiority over established zinc forms like zinc gluconate or zinc citrate for specific health outcomes.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*